Pepsi's slump is mainly due to aggressive price hikes and high T-bond yields, not diworsification or health trends.

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...

A 2023 test showing that Novo Nordisk (NYSE: NVO )’s Wegovy weight-loss medication not only helped people lose weight but ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

Can a diet pill treat cancer? There is fresh evidence that indicates type 2 diabetes and obesity medications GLP-1 receptor ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...

Rapid weight loss without adequate nutrition can lead to a reduction in lean muscle mass, and many patients experience ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...